-
4
-
-
1042301338
-
State-of-the-art treatment of high-grade brain tumors
-
Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol 2003; 30: 4-9.
-
(2003)
Semin Oncol
, vol.30
, pp. 4-9
-
-
Brandes, A.A.1
-
5
-
-
0013809401
-
Properties of deoxythymidine kinase partially purified from animal tumors
-
Bresnick E, Thompson UB. Properties of deoxythymidine kinase partially purified from animal tumors. J Biol Chem 1965; 240: 3967-3974.
-
(1965)
J Biol Chem
, vol.240
, pp. 3967-3974
-
-
Bresnick, E.1
Thompson, U.B.2
-
7
-
-
0035130544
-
Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model
-
Chi KH, Wang HE, Chen FD et al. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model. J Nucl Med 2001; 42: 345-351.
-
(2001)
J Nucl Med
, vol.42
, pp. 345-351
-
-
Chi, K.H.1
Wang, H.E.2
Chen, F.D.3
-
8
-
-
0013855384
-
Biological stability of 5-iodo-2′-deoxyuridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse
-
Commerford SL. Biological stability of 5-iodo-2′-deoxyuridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse. Nature 1965; 206: 949-950.
-
(1965)
Nature
, vol.206
, pp. 949-950
-
-
Commerford, S.L.1
-
9
-
-
0035503022
-
Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine
-
Dupertuis YM, Vazquez M, Mach JP et al. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine. Cancer Res 2001; 61: 7971-7977.
-
(2001)
Cancer Res
, vol.61
, pp. 7971-7977
-
-
Dupertuis, Y.M.1
Vazquez, M.2
Mach, J.P.3
-
10
-
-
0141728579
-
Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells
-
Eidinoff ML, Cheong L, Rich MA. Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells. Science 1959; 129: 1550-1551.
-
(1959)
Science
, vol.129
, pp. 1550-1551
-
-
Eidinoff, M.L.1
Cheong, L.2
Rich, M.A.3
-
11
-
-
0030119622
-
Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation
-
Foulon CF, Adelstein SJ, Kassis AI. Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation. J Nucl Med 1996; 37: 1S-3S.
-
(1996)
J Nucl Med
, vol.37
-
-
Foulon, C.F.1
Adelstein, S.J.2
Kassis, A.I.3
-
14
-
-
0018802009
-
Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2′-deoxyuridylate
-
Garrett C, Wataya Y, Santi DV. Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2′-deoxyuridylate. Biochemistry 1979; 18: 2798-2804.
-
(1979)
Biochemistry
, vol.18
, pp. 2798-2804
-
-
Garrett, C.1
Wataya, Y.2
Santi, D.V.3
-
15
-
-
6344228279
-
Current management of glioblastoma multiforme
-
Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol 2004; 31: 635-644.
-
(2004)
Semin Oncol
, vol.31
, pp. 635-644
-
-
Grossman, S.A.1
Batara, J.F.2
-
17
-
-
12344332475
-
The amazing world of auger electrons
-
Kassis AI. The amazing world of auger electrons. Int J Radiat Biol 2004; 80: 789-803.
-
(2004)
Int J Radiat Biol
, vol.80
, pp. 789-803
-
-
Kassis, A.I.1
-
18
-
-
14844359242
-
Radiobiologic principles in radionuclide therapy
-
Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med 2005; 46 Suppl 1: 4S-12S.
-
(2005)
J Nucl Med
, vol.46
, Issue.SUPPL. 1
-
-
Kassis, A.I.1
Adelstein, S.J.2
-
19
-
-
0033712605
-
In vivo therapy of neoplastic meningitis with methotrexate and 5
-
Kassis AI, Dahman BA, Adelstein SJ. In vivo therapy of neoplastic meningitis with methotrexate and 5. Acta Oncol 2000; 39: 731-737.
-
(2000)
Acta Oncol
, vol.39
, pp. 731-737
-
-
Kassis, A.I.1
Dahman, B.A.2
Adelstein, S.J.3
-
22
-
-
12344306166
-
125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis
-
125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. Int J Radiat Biol 2004; 80: 941-946.
-
(2004)
Int J Radiat Biol
, vol.80
, pp. 941-946
-
-
Kassis, A.I.1
Kirichian, A.M.2
Wang, K.3
-
23
-
-
0023134984
-
125IUdR in mammalian cells: Implications of localized energy deposition by Auger processes
-
125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat Res 1987; 109: 78-89.
-
(1987)
Radiat Res
, vol.109
, pp. 78-89
-
-
Kassis, A.I.1
Sastry, K.S.2
Adelstein, S.J.3
-
24
-
-
0025002682
-
125I]iodo- 2′-deoxyuridine in rat brain tumors: Diagnostic and therapeutic implications in humans
-
125I]iodo- 2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990; 50: 5199-5203.
-
(1990)
Cancer Res
, vol.50
, pp. 5199-5203
-
-
Kassis, A.I.1
Van den Abbeele, A.D.2
Wen, P.Y.3
-
25
-
-
0021996048
-
Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodo uracil and endogenous pyrimidine modulation
-
Klecker RW Jr, Jenkins JF, Kinsella TJ et al. Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodo uracil and endogenous pyrimidine modulation. Clin Pharmacol Ther 1985; 38: 45-51.
-
(1985)
Clin Pharmacol Ther
, vol.38
, pp. 45-51
-
-
Klecker Jr, R.W.1
Jenkins, J.F.2
Kinsella, T.J.3
-
26
-
-
33745010017
-
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
-
Mirimanoff RO, Gorlia T, Mason W et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006; 24: 2563-2569.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2563-2569
-
-
Mirimanoff, R.O.1
Gorlia, T.2
Mason, W.3
-
27
-
-
0031059777
-
Incorporation of iododeoxyuridine in multicellular glioma spheroids: Implications for DNA-targeted radiotherapy using Auger electron emitters
-
Neshasteh-Riz A, Angerson WJ, Reeves JR et al. Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer 1997; 75: 493-499.
-
(1997)
Br J Cancer
, vol.75
, pp. 493-499
-
-
Neshasteh-Riz, A.1
Angerson, W.J.2
Reeves, J.R.3
-
28
-
-
0029743456
-
Targeted radiotherapy using Auger electron emitters
-
O'Donoghue JA, Wheldon TE. Targeted radiotherapy using Auger electron emitters. Phys Med Biol 1996; 41: 1973-1992.
-
(1996)
Phys Med Biol
, vol.41
, pp. 1973-1992
-
-
O'Donoghue, J.A.1
Wheldon, T.E.2
-
30
-
-
0030879122
-
Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype
-
Parsels LA, Zellars RC, Loney TL et al. Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype. Mol Pharmacol 1997; 52: 600-605.
-
(1997)
Mol Pharmacol
, vol.52
, pp. 600-605
-
-
Parsels, L.A.1
Zellars, R.C.2
Loney, T.L.3
-
33
-
-
34250328632
-
123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines
-
123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines. J Nucl Med 2007; 48: 1000-1007.
-
(2007)
J Nucl Med
, vol.48
, pp. 1000-1007
-
-
Reske, S.N.1
Deisenhofer, S.2
Glatting, G.3
-
34
-
-
2342512808
-
125I] iodo-2′-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy
-
125I] iodo-2′-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy. Nucl Med Commun 2004; 25: 461-468.
-
(2004)
Nucl Med Commun
, vol.25
, pp. 461-468
-
-
Schaffland, A.O.1
Delaloye, A.B.2
Kosinski, M.3
-
35
-
-
0031855690
-
Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells
-
Sedelnikova OA, Panyutin IG, Thierry AR, Neumann RD. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. J Nucl Med 1998; 39: 1412-1418.
-
(1998)
J Nucl Med
, vol.39
, pp. 1412-1418
-
-
Sedelnikova, O.A.1
Panyutin, I.G.2
Thierry, A.R.3
Neumann, R.D.4
-
36
-
-
0021893190
-
3H]thymidine incorporation by Mycoplasma arginini-infected cells due to enzymatic cleavage of the nucleoside
-
3H]thymidine incorporation by Mycoplasma arginini-infected cells due to enzymatic cleavage of the nucleoside. Eur J Immunol 1985; 15: 692-696.
-
(1985)
Eur J Immunol
, vol.15
, pp. 692-696
-
-
Sinigaglia, F.1
Talmadge, K.W.2
-
37
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
-
39
-
-
0028117269
-
Analysis of the p53 gene and its expression in human glioblastoma cells
-
Van Meir EG, Kikuchi T, Tada M et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 1994; 54: 649-652.
-
(1994)
Cancer Res
, vol.54
, pp. 649-652
-
-
Van Meir, E.G.1
Kikuchi, T.2
Tada, M.3
-
40
-
-
70350318123
-
Cellular damage in vitro - Influence of β-energy and intra cellular radionuclide uptake
-
Wendisch M, Drechsel J, Freudenberg R et al. Cellular damage in vitro - Influence of β-energy and intra cellular radionuclide uptake. Nuklearmedizin 2009; 48: 208-214.
-
(2009)
Nuklearmedizin
, vol.48
, pp. 208-214
-
-
Wendisch, M.1
Drechsel, J.2
Freudenberg, R.3
-
42
-
-
0037109016
-
Bystander effect produced by radiolabeled tumor cells in vivo
-
Xue LY, Butler NJ, Makrigiorgos GM et al. Bystander effect produced by radiolabeled tumor cells in vivo. Proc Natl Acad Sci USA 2002; 99: 13765-13770.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 13765-13770
-
-
Xue, L.Y.1
Butler, N.J.2
Makrigiorgos, G.M.3
|